Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design (Q36837134)

16 August 2017

1 reference

title

Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design (English)

1 reference

16 August 2017

1 reference

Christopher A Lazarski

4

object named as

Christopher A Lazarski

1 reference

16 August 2017

Andrea J Sant

1

1 reference

16 August 2017

Francisco A Chaves

2

1 reference

16 August 2017

Frederick R Krafcik

3

1 reference

16 August 2017

Paula Menges

5

1 reference

16 August 2017

Katherine Richards

6

1 reference

16 August 2017

Jason M Weaver

7

1 reference

16 August 2017

1 June 2007

1 reference

Expert Review of Vaccines

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

3

1 reference

16 August 2017

357-368

1 reference

Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses

16 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Dominance and crypticity of T cell antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Reversal of immunodominance among autoantigenic T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Modulation of the immunogenicity of antigenic determinants by their flanking residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Determinant selection for T-cell tolerance in HEL-transgenic mice: dissociation between immunogenicity and tolerogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Endogenous antigen presentation by MHC class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Autophagy and antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Autophagy in MHC class II antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Autophagy and intracellular surveillance: Modulating MHC class II antigen presentation with stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Control of antigen presentation by a single protease cleavage site

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

A closer look at proteolysis and MHC-class-II-restricted antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Lysosomal cysteine proteases regulate antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Endosomal proteases in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Structural basis for helper T-cell and antibody epitope immunodominance in bacteriophage T4 Hsp10. Role of disordered loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Proteases involved in MHC class II antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Lysosomal cysteine proteases: facts and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Cysteine cathepsins in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The lysosomal cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Class II MHC peptide loading by the professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Specific role for cathepsin S in the generation of antigenic peptides in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Cutting edge: editing of recycling class II:peptide complexes by HLA-DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Mediation by HLA-DM of dissociation of peptides from HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

"Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

DM determines the cryptic and immunodominant fate of T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Quality control of MHC class II associated peptides by HLA-DM/H2-M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Helper T-cell-regulated B-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Influenza virus evades innate and adaptive immunity via the NS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

A mouse model for immunization with ex vivo virus-infected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Autophagy in innate and adaptive immunity against intracellular pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Presentation of cytosolic antigens via MHC class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Uneven distribution of MHC class II epitopes within the influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The virosome concept for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Checkpoints in memory B-cell evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The effect of B cell receptor signaling on antigen endocytosis and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Neurological Manifestations of Avian Influenza Viruses in Mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Pathogenesis of and immunity to avian influenza A H5 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

CD4+ memory T cells: functional differentiation and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Immunological memory to viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

T cell homeostasis: keeping useful T cells alive and live T cells useful

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

T-cell memory and recall responses to respiratory virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Memory T cell recruitment to the lung airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

T cell memory in the lung airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Signaling control of memory T cell generation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Control of influenza virus infection by immunity to conserved viral features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

Antigen-specific interaction between T and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.357

21 January 2018

Identifiers

DOI

10.1586/14760584.6.3.357

1 reference

16 August 2017

1 reference